An Australian stem cell and regenerative medicine company

ASX Announcements

20 Jun 2016 Cynata Prepares for Phase 1 Clinical Trial
09 Jun 2016 Initial Director's Interest Notice
08 Jun 2016 Cynata Appoints Paul K Wotton Ph.D. to Board of Directors
08 May 2016 Cynata Enters Agreement with apceth GmbH & Co KK
05 May 2016 CYP Manufactures CT Product; Files Further Patent Application
02 May 2016 Decision to Grant Patent for Cymerus MSC Technology in Japan
29 Apr 2016 Cynata & Regience Extend Entitlement Period
06 Apr 2016 Compelling Results from Pre-Clinical Stem Cell Study in GvHD
02 Mar 2016 Cynata Enters Agreement for Strategic Alliance in Japan
15 Feb 2016 Cyanta Receives $930k R&D Tax Incentive Refund
27 Jan 2016 CYP Receives Favourable Advice from UK Regulatory Authority
11 Jan 2016 Cynata CLI Study Published in Peer Reviewed Journal
16 Dec 2015 Cynata Enters Letter of Intent for a Commercial Partnership
07 Dec 2015 Rodman & Renshaw Initiates Cynata Research Coverage
02 Dec 2015 CYP Enters Letter of Intent for Strategic Alliance in Japan
30 Nov 2015 Expiry of Unlisted Options
10 Nov 2015 Results of Annual General Meeting
05 Nov 2015 Restricted Securities to be Released from Escrow
04 Nov 2015 Cynata Engages CRO to Conduct GvHD Clinical Trial
13 Oct 2015 CYP in Major New Collaboration for Cell Therapy for Cancer
05 Oct 2015 Notice of Annual General Meetin/Proxy Form
06 Sep 2015 Cynata to Present at Rodman & Renshaw Investment Conference
02 Sep 2015 SeeThruEquity Initiates Cynata Research Coverage
20 Aug 2015 Appendix 4G
29 Jul 2015 Cynata in Heart Disease Collaboration with Uni of Sydney
16 Jul 2015 Information Required Under Listing Rule 3.10.5A
16 Jul 2015 Appendix 3B
14 Jul 2015 Section 708A Notice
14 Jul 2015 Private Placement to US Institutional Investors Completed
24 May 2015 R&D Tax Incentive
20 May 2015 Cynata-Cymerus Progress Report
07 May 2015 ASX Price Query
29 Mar 2015 Appendix 3Y-John Chiplin
17 Mar 2015 Cynata CEO to Chair World Congress Session on Stem Cells
15 Mar 2015 Appendix 3Y-Stewart Washer
15 Mar 2015 Executive Services Contracts Renewed/Vesting Conditions Met
11 Mar 2015 Commences Further Stage of Stem Cell Manufacturing Program
05 Mar 2015 Director Options Vesting Condition Met
04 Mar 2015 Cynata Presenting at 8th Annual ASX Spotlight New York 2015
19 Feb 2015 BBY Updates Cynata Research Coverage
18 Feb 2015 Cynata Achieves Major Stem Cell Manufacturing Milestone
16 Feb 2015 Trading Halt
15 Feb 2015 Cynata Engages CRO to Plan Clinical Trial
12 Feb 2015 Change of Share Registry
11 Feb 2015 Cynata Engages Leading US Investor Relations Firm
02 Feb 2015 Cynata Partners with University of Western Australia
14 Jan 2015 Top 20 Shareholders
13 Jan 2015 Section 708A Notice
13 Jan 2015 Appendix 3B
05 Jan 2015 Section 708A Notice